In addition, a further study found that allicin could improve the radiosensitivity of colorectal cancer cells by inhibiting the NF-κB signaling pathway in the BALB/c mouse model, which suggests that allicin may be used as a potential sensitizer in clinical tumor radiotherapy (Huang et al., 2020). This evidence concerns the gene NFKB1 and neoplasm.